EU Parliament medtech report details rocky reg road ahead
This article was originally published in Clinica
Executive Summary
A sense of shock pervaded the medtech industry immediately after the 15 April publication of a draft report by the European Parliament’s rapporteur of the ENVI committee, Dagmar Roth-Behrendt, on the future regulation of medical devices. Controversial points made in the report include, among other things the introduction of premarket authorisation for medical devices and the re-use of all devices.
You may also be interested in...
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.